نتایج جستجو برای: mullerian hormone receptor

تعداد نتایج: 696042  

Journal: :galen medical journal 0
mehrnoosh etemadi students’ scientific research center, tehran university of medical sciences, tehran mohammad mahdi zamani students’ scientific research center, tehran university of medical sciences, tehran department of anesthesiology and critical care, tehran university of medical sciences, tehran amir masoud nazemi blood transfusion research center, high institute for research and education in transfusion medicine, iranian blood transfusion organization, tehran afsaneh rajabiani department of pathology, school of medicine, tehran university of medical sciences, tehran alireza abdollahi department of pathology, school of medicine, tehran university of medical sciences, tehran

background : breast cancer is one of the most frequent malignancies among iranian women. triple-negative breast cancer (tnbc) is referred to a type of breast cancer which three biomarkers of estrogen receptor, progesterone receptor, and human epidermal growth factor receptor 2 (her2), are negative. materials and methods: in this case control study, immunohistopathologic data of patients with tn...

Journal: :Endocrine reviews 1993
M M Lee P K Donahoe

Mullerian inhibiting substance (MIS) is the gonadal hormone that causes regression of the Mullerian ducts, the anlagen of the female internal reproductive structures, during male embryogenesis. MIS is a member of the large transforming growth factor-beta (TGF beta) multigene family of glycoproteins that are involved in the regulation of growth and differentiation. The proteins in this gene fami...

2014
BUSHRA FIZA RATI MATHUR MAHEEP SINHA PUSHPENDRA SARASWAT

As the chronological age increases, there is a physiological decline in reproductive potential of women. Moreover, the chronological age of women may not reflect the biological age of her ovaries. Various endocrine markers have been used to assess the ovarian reserve. The changing pattern of the endocrine markers; follicle stimulating hormone (FSH), luteinizing hormone (LH), estradiol (E2) and ...

Ali Moradi, Alireza Raeissi Alireza Torki Masoud Doosti Pirani Seyed Mehdi Mousavipoor

Background Anti-Müllerian hormone (AMH) is secreted by the granulosa cells of growing follicles during the primary to large antral follicle stages. Abnormal levels of AMH and follicle stimulating hormone (FSH) may indicate a woman’s diminished ability or inability to conceive. Our aim is to investigate the changes in serum AMH and FSH concentrations at different age groups and its correlation w...

2013
Kai J. Buhling Petra Stute Volker Ziller

Anti-Mullerian hormone (AMH) is a protein that inhibits the development of the mullerian ducts (paramesonephric ducts) in the male embryo. AMH prevents the development of the mullerian ducts into the uterus and other mullerian structures in the first 8 weeks of gestational age. AMH is produced by granulosa cells of the ovary during the reproductive years and controls the formation of primary fo...

2018

Submit Manuscript | http://medcraveonline.com Abbreviations: AMH: Anti-Mullerian Hormone; AR: Androgen Receptors; ATF3: Activating Transcription Factor 3; CPAs: Congenital Penile Anomalies; CWH: Chordee Without Hypospadias; EDCs: Endocrine Disrupting Chemicals; KFS: Klinefelter Syndrome; LUTS: Lower Urinary Tract Symptoms; MAGPI: Meatal Advancement and Glanuloplasty Incorporated; SMR: Split Med...

2013
M. Dólleman M. J. Faddy J. van Disseldorp Y. T. van der Schouw C. M. Messow B. Leader P. H. M. Peeters A. McConnachie S. M. Nelson F. J. M. Broekmans

(2013) The relationship between anti-mullerian hormone in women receiving fertility assessments and age at menopause in subfertile women: evidence from large population studies. The content must not be changed in any way or reproduced in any format or medium without the formal permission of the copyright holder(s) When referring to this work, full bibliographic details must be given

2014
Lisa M. Pastore Joshua Johnson

The strongest association between FMR1 and the ovary in humans is the increased risk of premature ovarian failure (POF) in women who carry the premutation level of CGG repeats (55-199 CGGs). Research on the FMR1 gene has extended to other endpoints of relevance in the OB/GYN setting for women, including infertility and ovarian hormones. After reviewing the nomenclature changes that have occurre...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید